It feels truly surreal to be entering this hematology-oncology fellowship application cycle, pursuing my passion for GIOncology. My interests focus on GI cancers, early-onset malignancies, and healthcare disparities, with a special focus on clinical trials. Grateful to all my

Publication Alert🔔 Pancreatic cancer remains one of the toughest cancers. But progress is being made from better surgery and neoadjuvant strategies to targeted therapies. mdpi.com/3414734 #mdpiijms via IJMS MDPI OncoDaily Ehab Takrori @sakshisingal2 Faizan B

Worshipping a celebrity is associated with lower cognitive abilities.

At the end of the day, it’s on you. Don’t wait for anyone to save you…most people won’t. A few might care, but even fewer will show up. Build yourself, because no one’s coming to do it for you.

In our recent study, we looked at whether children with bedwetting (primary nocturnal enuresis) are more likely to have joint hypermobility by evaluating Beighton score. We used univariate and multivariate statistical analysis. Check the full paper at link.springer.com/article/10.118…

Belumosudil (ROCK2 inhibitor) offers hope for patients with chronic GVHD who fail prior therapies, approved by the FDA in July 2021 for patients aged ≥12 years with cGVHD after failure of ≥2 prior lines of systemic therapy.

Interesting read !! 📕 Association Between Metabolic Syndrome and Risk of Laryngeal Cancer: A Systematic Review mdpi.com/3587094 #mdpicurroncol via Current Oncology Faizan B lalith Sakshi Singal OncoDaily IMG Oncologists H.O.M.E Hem-Onc Fellows Network

God's plan, alwayyyyyyyys.